Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.36B |
| Enterprise Value | 16.8B |
| P/E Ratio | -8.46 |
| PEG Ratio | 1.07 |
| Price/Sales Ratio | 11.96 |
| Price/Book Ratio | 13.36 |
| Enterprise/Revenue | 13.88 |
| Enterprise/EBITDA | -11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -1.46 |
| Operating Margin | -1.33 |
AD
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -2.05 |
Income Statement
| Revenue | 662.52M |
| Revenue/Share | 1.61 |
| Gross Profit | 662.52M |
| EBITDA | -737.97M |
| Net Income | -970.18M |
| Diluted EPS | -2.43 |
Balance Sheet
| Total Cash | 2.32B |
| Total Cash/Share | 5.22 |
| Total Debt | 3.69B |
| Total Debt/Equity | 5.15 |
| Current Ratio | 1.53 |
| Book Value Per Share | 2.01 |
Price History
| 52-Week Change | -49.41 |
| 52-Week High | 47.8 |
| 52-Week Low | 19.77 |
| Moving Average 50 Days | 24.53 |
| Moving Average 200 Days | 30.92 |
Statistics
| Average Volume | 7.86M |
| Shares Outstanding | 399.6M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
